Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Endomimetics Awarded $100,000 Grant from Innovate Alabama to Support Development and Evaluate Potential of Bionanomatrix™ for Knee Arthroplasty Complications
Jul 09, 2024
Contract Type
partnership
BirminghamBiotechnologyHealth Care
Description
Endomimetics has been awarded a $100,000 grant from Innovate Alabama to support research aimed at developing and evaluating the potential of a Bionanomatrix™ formulation to reduce infectious and inflammatory complications following knee replacement. This grant supplements the previously awarded $292 thousand one-year NIH/SBIR grant to support this indication.
Company Information
Company
Endomimetics
Location
Birmingham, Alabama, United States
About
Endomimetics is the developer of Bionanomatrix™, a peptide-based biomaterial used to promote healing and improve outcomes following medical device implantation and other procedures.
Predictive Intelligence
Strategic
ML-powered predictions for Endomimetics's next move